Device Trial Radar · NCT07100834
Pulsed ElectRic FiEld Versus Cryoballoon for PAF
Last checked: Nov 19, 2026Latest source record: Aug 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
269
Actual
Start
Sep 27, 2023
Primary completion
May 30, 2024
Study completion Jun 30, 2025
Sponsor
- Lead sponsor
- Universitair Ziekenhuis BrusselAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 3, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study has been designed to compare the success rate of two different commercially available ablation technologies, namely PFA and Cryo. Both technologies are standard of care ablation procedures. An ablation is a procedure where a small piece of tissue of the heart, that. causes an irregular heartbeat, is heated or frozen (cryo-ablation) using a special type of catheter. Once you have signed this consent to take part of the study, you will be randomly assigned to one of the two ablation strategies (PFA versus Cryo). Randomization is a method that helps prevent any possible influence of human choices on clinical results and improve objectivity in research. The day of the procedure you will be undergo AF catheter ablation via either PFA or Cryo based on the results of randomization. Although both devices that will be used in this study are commercially approved, assessing the incidence of arrhythmia recurrence after ablation during follow-up is considered the investigational portion of the study. "Investigational" means that recurrence data will be collected after the cardiac ablation procedure and compared amongst the two standard of care ablation methods used to treat AF. This study will investigate how well PFA and Cryo work to prevent recurrences of atrial arrhythmias and if there are any differences between the two technologies
Conditions
- Atril Fibrillation
- Cardiac Arrhythmia
- Paroxysmal Atrial Fibrillation (PAF)
Interventions
Single-Shot Pulsed Field Ablation (FARAPULSE™ Pulsed Field Ablation System)Device
The FARAPULSE™ Pulsed Field Ablation System (Boston Scientific, Inc.) is a CE-marked system consisting of the FARASTAR™ Pulsed Field Ablation Generator that is used with the FARAWAVE™ Pulsed Field Ablation Catheter for cardiac tissue ablation
Single-Shot Cryoballoon Devices (Arctic Front Advance PRO, Medtronic Inc., Minneapolis, MN, USA; POLARx and POLARx FIT Balloon Catheter, Marlborough, MA, USA)Device
The Arctic Front Advance PRO, POLARx and FIT Balloon Catheters are CE-marked cryoablation systems consisting of a cryoballoon device, which is used in conjunction with a CryoConsole, a steerable sheath, and a circular mapping catheter
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Efficacy EndpointTime frame: 0-36 months
Locations
6 sites in 5 countries. Site status is shown where the registry gives one.
Universitair Ziekenhuis Brussel
Brussels, Belgium
Department of Cardiovascular Diseases, University Hospital Center Zagreb
Zagreb, Croatia
9. First Department of Cardiology, National and Kapodistrian University of Athens Medical School, Hippokration General Hospital
Athens, Greece
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.